AVO.L
Advanced Oncotherapy plc [AVO.L] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
AVO.L Stock Summary
In the News
AVO.L Financial details
Company Rating
-
Market Cap
9.5M
Income
-32.6M
Revenue
0
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
174
Optionable
No
Shortable
Yes
Earnings
13 Feb 2024
P/E
-0.19
Forward P/E
-
PEG
0.09
P/S
-
P/B
0.11
P/C
-
P/FCF
-0.24
Quick Ratio
0.26
Current Ratio
1.91
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-0.07
EPS next Y
-
EPS next Q
-
EPS this Y
-
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-
Revenue last 5Y
-
Revenue Q/Q
-
EPS Q/Q
-
-
-
-
-
SMA20
-
SMA50
-
SMA100
-
Inst Own
-
Inst Trans
-
ROA
-25%
ROE
-67%
ROC
-0.19%
Gross Margin
-
Oper. Margin
-
Profit Margin
-
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
0.0-25.748
52W High
-
52W Low
-
RSI
-
Rel Volume
29.78
Avg Volume
543.97K
Volume
-
Perf Week
-
Perf Month
-
Perf Quarter
-
Perf Half Y
-
-
-
-
-
Beta
0.068
-
-
Volatility
0.82%, 0.82%
Prev Close
-
Price
-
Change
-
Company Profile
- Volume Average 543.97K
- Market Capitalization 9.5M
- Employee 174
- CEO Mr. Nicolas Serandour
- Headquarters London,GB
- IPO Date 2006-08-04
-
Website
https://www.avoplc.com 
Advanced Oncotherapy plc, together with its subsidiaries, engages in the designing, assembling, and selling proton-based radiotherapy systems for treatment of cancer. It is developing Linac Image Guided Hadron Technology, a proton therapy system for treating cancer. The company also engages in the management of healthcare related properties. It has operations in the United Kingdom, Switzerland, and the United States. The company was formerly known as CareCapital Group plc and changed its name to Advanced Oncotherapy PLC in September 2012. Advanced Oncotherapy plc was founded in 1994 and is headquartered in London, the United Kingdom.
